Berkery Noyes discusses the growing popularity of RWD and RWE in a byline article for Health IT Outcomes. Stakeholders are investing heavily in resources to build their internal RWD capabilities. RWE is being used by payors, providers, and pharmaceutical companies to help make decisions about cost effectiveness and usefulness, especially when other data sources are lacking. Both strategic and financial acquirers are continuing to look for opportunities in this space.